Status:
UNKNOWN
Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients
Lead Sponsor:
Erasme University Hospital
Conditions:
Fiberoptic Bronchoscopy (FOB)
Bronchoalveolar Lavage (BAL)
Eligibility:
All Genders
18+ years
Brief Summary
Fiberoptic bronchoscopy (FOB) is widely used as a diagnostic or therapeutic procedure in intensive care units. Patients with ARDS or COVID-19 disease often undergoes to these procedures. However, inte...
Detailed Description
Fiberoptic bronchoscopy (FOB) is widely used in intensive care units as a diagnostic or therapeutic procedure. FOB in respiratory failure patients supported by mechanical ventilation may worsen hypoxe...
Eligibility Criteria
Inclusion
- Mechanically ventilated ICU patients requiring a FOB or FOB + BAL
Exclusion
- PaO2/FiO2 ratio \<100
- Age \< 18 years
- Pregnancy
- Unstable angina and recent (less than 1 week) myocardial infarction
- Uncontrolled cranial hypertension
- Major hemodynamic instability
- Any previous lung surgery (except for lung transplantation)
- Obesity (BMI \> 50)
- Chest circumference \> 150 cm
- Electronic implanted device (pacemaker, neurostimulator, etc.)
- Patients who had undergone several bronchoscopy procedures could not be included twice.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04502368
Start Date
September 1 2020
End Date
April 30 2021
Last Update
February 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasme University Hospital - Intensive Care Unit
Brussels, Belgium, 1070